Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$159.90
-1.73%
Mkt Cap $16.40B
Analyst Ratings
Buy
27
Hold
3
Sell
0
Price Target (64 analysts)
$173.67
Range $140.00 – $220.00
Implied Upside
+8.6%
Consensus $173.67 vs current $159.90